AIM ImmunoTech’s Proxy Contest

Laura Testa North America Legal Chronicle
Tagged:

Kirkland & Ellis advised AIM ImmunoTech on the deal.AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here